News Overview

Promoter/Promoter Group of Vindhya Telelinks Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Promoter/Promoter Group of 3M India Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

MARKSANS : Significant movement in price has been observed in Marksans Pharma Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Marksans Pharma Limited has submitted their response.

Promoter/Promoter Group of Sun Pharma Advanced Research Company Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Gufic Biosciences Limited has informed the Exchange about press release dated 11-Apr-2022 titled Gufic receives permission from CDSCO to manufacture and sale Isavuconazonium Sulfate API and Finished formulation Isavuconazole for Injection 200 mg/vial

Promoter/Promoter Group of Texmaco Rail & Engineering Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Promoter/Promoter Group of Magadh Sugar & Energy Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Promoter/Promoter Group of Tci Finance Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Promoter/Promoter Group of Titagarh Wagons Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations andDisclosure Requirements) Regulations, 2015 (???Listing Regulations???) ??? Updated Investor Presentation